Effects of Gadolinium Deposition in the Brain on Motor or Behavioral Function: A Mouse Model.
Hiroyuki AkaiKazuya MiyagawaKohei TakahashiAtsumi Mochida-SaitoKazuhiro KurokawaHiroshi TakedaMinoru TsujiHaruto SugawaraKoichiro YasakaAkira KunimatsuYusuke InoueSusumu MoriKuni OhtomoShigeru KiryuPublished in: Radiology (2021)
Background Recent studies showing gadolinium deposition in multiple organs have raised concerns about the safety of gadolinium-based contrast agents (GBCAs). Purpose To explore whether gadolinium deposition in brain structures will cause any motor or behavioral alterations. Materials and Methods This study was performed from July 2019 to December 2020. Groups of 17 female BALB/c mice were each repeatedly injected with phosphate-buffered saline (control group, group A), a macrocyclic GBCA (group B), or a linear GBCA (group C) for 8 weeks (5 mmol per kilogram of bodyweight per week for GBCAs). Brain MRI studies were performed every other week to observe the signal intensity change caused by the gadolinium deposition. After the injection period, rotarod performance test, open field test, elevated plus-maze test, light-dark anxiety test, locomotor activity assessment test, passive avoidance memory test, Y-maze test, and forced swimming test were performed to assess the locomotor abilities, anxiety level, and memory. Among-group differences were compared by using one-way or two-way factorial analysis of variance with Tukey post hoc testing or Dunnett post hoc testing. Results Gadolinium deposition in the bilateral deep cerebellar nuclei was confirmed with MRI only in mice injected with a linear GBCA. At 8 weeks, contrast ratio of group C (0.11; 95% CI: 0.10, 0.12) was higher than that of group A (-2.1 × 10-3; 95% CI: -0.011, 7.5 × 10-3; P < .001) and group B (2.7 × 10-4; 95% CI: -8.2 × 10-3, 8.7 × 10-3; P < .001). Behavioral analyses showed that locomotor abilities, anxiety level, and long-term or short-term memory were not different in mice injected with linear or macrocyclic GBCAs. Conclusion No motor or behavioral alterations were observed in mice with brain gadolinium deposition. Also, the findings support the safety of macrocyclic gadolinium-based contrast agents. © RSNA, 2021 Online supplemental material is available for this article. See also the editorial by Chen in this issue.
Keyphrases
- contrast enhanced
- magnetic resonance imaging
- magnetic resonance
- spinal cord injury
- mouse model
- white matter
- high fat diet induced
- resting state
- computed tomography
- randomized controlled trial
- healthcare
- working memory
- high resolution
- adipose tissue
- diffusion weighted imaging
- multiple sclerosis
- high intensity
- mass spectrometry
- blood brain barrier
- ultrasound guided
- neural network